WNK2 and depressive symptom measurement: Additional studies are warranted to investigate the molecular mechanisms that underlie the beneficial effects of pentoxifylline against mania-like and depression-like behavior in animals, including the mitogen-activated protein kinases and nuclear factor kappa B pathways.